Correlation Between Microsoft Corp and Appili Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft Corp and Appili Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft Corp and Appili Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft Corp CDR and Appili Therapeutics, you can compare the effects of market volatilities on Microsoft Corp and Appili Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft Corp with a short position of Appili Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft Corp and Appili Therapeutics.

Diversification Opportunities for Microsoft Corp and Appili Therapeutics

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Microsoft and Appili is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft Corp CDR and Appili Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Appili Therapeutics and Microsoft Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft Corp CDR are associated (or correlated) with Appili Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Appili Therapeutics has no effect on the direction of Microsoft Corp i.e., Microsoft Corp and Appili Therapeutics go up and down completely randomly.

Pair Corralation between Microsoft Corp and Appili Therapeutics

Assuming the 90 days trading horizon Microsoft Corp CDR is expected to generate 0.11 times more return on investment than Appili Therapeutics. However, Microsoft Corp CDR is 9.2 times less risky than Appili Therapeutics. It trades about 0.39 of its potential returns per unit of risk. Appili Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  2,601  in Microsoft Corp CDR on April 21, 2025 and sell it today you would earn a total of  1,074  from holding Microsoft Corp CDR or generate 41.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Microsoft Corp CDR  vs.  Appili Therapeutics

 Performance 
       Timeline  
Microsoft Corp CDR 

Risk-Adjusted Performance

Strong

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft Corp CDR are ranked lower than 30 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal technical and fundamental indicators, Microsoft Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.
Appili Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Appili Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in August 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Microsoft Corp and Appili Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microsoft Corp and Appili Therapeutics

The main advantage of trading using opposite Microsoft Corp and Appili Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft Corp position performs unexpectedly, Appili Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will offset losses from the drop in Appili Therapeutics' long position.
The idea behind Microsoft Corp CDR and Appili Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device